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Development of neurogenic pulmonary edema can pre-vent the use of donor lungs for transplantation. We pre-sent a case in which severe preoperative donorneurogenic pulmonary edema was overcome after trans-
plantation with the use of extracorporeal membrane oxygenation. 
Clinical Summary
Donor. A 17-year-old child was pronounced dead after a
gunshot wound to the head. Soon after consent for organ dona-
tion had been obtained from the family, significantly worsening
oxygenation was noted despite diuretics and pulmonary therapy
(Table 1). The initial trauma chest x-ray film was clear; however,
a follow-up chest x-ray film was consistent with the develop-
ment of severe pulmonary edema in both lungs. During this
period, the mean blood pressure was at least 65 mm Hg, exten-
sive fluid resuscitation was not necessary, and a drug screen was
negative. Thus, it was believed that the donor’s pulmonary
edema was neurogenic in origin.
Recipient. A 55-year-old woman had severe pulmonary fibro-
sis: forced expiratory volume in 1 second of 0.71 L and forced vital
capacity of 0.85 L, 33% and 30% of predicted, respectively; room
air blood gas pH, 7.40; PCO2, 48 mm Hg; and PO2, 53 mm Hg. This
patient required 5 L of oxygen to maintain an oxygen saturation of
88%. Her survival without a transplant was estimated to be less
than 3 months. The patient arrived at our facility shortly after the
donor became available. After arrival, she was noted to be pro-
foundly dyspneic while breathing 5 L of oxygen and was believed
to have had an even further decline in pulmonary function com-
pared with her last evaluation. 
Because this might be the recipient’s only chance to undergo
lung transplantation, a conference was held with the recipient and
her family. After extensive discussions, the decision was made to
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proceed with the operation despite the development of rapidly pro-
gressing pulmonary edema in the donor. Preoperatively, the patient
was informed of the tentative plan to proceed with extracorporeal
membrane oxygenation (ECMO) after the transplant operation to
allow time for the donor lungs to recover.
The donor was taken to the operating room. After a median
sternotomy, pulmonary artery alprostadil injection, and Euro-
Collins solution flush, the heart-lung block was harvested without
difficulty. The lungs and heart were then separated. The recipient
meanwhile underwent a median sternotomy followed by institution
of cardiopulmonary bypass. The patient underwent right lung
transplantation first with a total ischemic time of 45 minutes. The
left lung was then transplanted with a total ischemic time of 90
minutes. After ventilation and perfusion of both lungs, a trial off
cardiopulmonary bypass was attempted. During this trial, the
patient had extremely poor oxygenation as a result of the severely
edematous lungs (Table 2). ECMO was instituted in the operating
room with the use of a central venous–pulmonary artery circuit.
The patient was then transferred to the intensive care unit.
Oxygenation on ECMO is shown in Table 2. The patient was
weaned from ECMO after 2 days and was discharged to her home
on hospital day 38. Early follow-up pulmonary function tests on
this patient demonstrated excellent lung function: forced expira-
tory volume in 1 second, 1.95 L (96%); forced vital capacity, 2.37 L
(87%); and total lung capacity, 2.96 L (72%). The patient has good
pulmonary function and has minimal exercise limitation.
Discussion
Neurogenic pulmonary edema can occur after brain injury,
seizure, hydrocephalus, or brain death and can result in signifi-
cant pulmonary dysfunction.1 Despite extensive investigations,
the mechanisms involved in the development of neurogenic pul-
monary edema are not completely understood. One theory sug-
gests that central mechanisms alter pulmonary endothelial
permeability, leading to an increase in lung edema formation.2
Another theory supports the view that high intravascular pres-
sures, possibly as a result of catecholamine release, directly
damages pulmonary endothelium and leads to subsequent edema
formation.3 Finally, some have suggested that a transient eleva-
tion in left-sided cardiovascular pressures or vasoconstriction
contributes to the development of pulmonary edema.1 Mortality
for patients with neurogenic pulmonary edema is over 50% in
some series. However, this was related to the neurologic dys-
function and not the respiratory failure.1
Given that the neurogenic pulmonary edema was likely reversible
and that the native pulmonary function of the recipient was deterio-
rating rapidly, we believed the best decision was to proceed with
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transplantation. This decision was made with the understanding that
the recipient would almost certainly initially have severe oxygenation
difficulties that could be temporarily overcome with the use of
ECMO. Ventilatory support would allow time for the lungs to recover
from the neurogenic pulmonary edema that occurred in the donor. We
and others have used ECMO after lung transplantation with some
success. At our institution, a total of 10 lung transplant recipients
required postoperative ECMO, of whom 4 (40%) have survived.4
Meyers and associates5 recently reported on 12 patients requiring
ECMO after lung transplantation. Overall survival in that study was
58% (7/12). We believe, however, that this is the first reported suc-
cessful use of ECMO in a recipient receiving lungs from a donor with
severe preoperative neurogenic pulmonary edema.
In summary, neurogenic pulmonary edema can be an impedi-
ment to the use of donor lungs for transplantation. This process can
be temporarily overcome with the use of ECMO, which allows
time for the donor lungs to recover. Although we would not rec-
ommend the routine use of lungs with neurogenic pulmonary
edema, consideration should be given to using lungs with this type
of dysfunction in recipients who are unlikely to survive long
enough for another donor to become available. 
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TABLE 1.  Donor management
Time FIO2 PEEP (cm H2O) PO2 (mm Hg) PO2/FIO2 ratio
0 1 5 414 414
700 1 10 359 359
1400 0.7 5 94 133
FIO2, Inspired oxygen fraction; PEEP, positive end-expiratory pressure; PO2,
oxygen tension.
TABLE 2.  Recipient management
Arterial
Date Time Support blood gases*
May 20 1850 Off CPB 7.31/49/72
1910 Off CPB 7.28/53/53
1918 On CPB
2020 On ECMO, FIO2 = 1.0 7.47/29/570
May 21 3 On ECMO, FIO2 = 0.45 7.34/26/169
2000 On ECMO, FIO2 = 0.45 7.52/23/255
May 22 700 On ECMO, FIO2 = 0.21 7.44/28/233
1248 Off ECMO, Vent. FIO2 = 1.0 7.46/36/182
CPB, Cardiopulmonary bypass; ECMO, extracorporeal membrane oxy-
genation; Vent., ventilator.
*pH, PCO2 (mm Hg), PO2 (mm Hg).
